Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Grifols Sa ADR (GIKLY)

Grifols Sa ADR (GIKLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.06
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.0000 unch
on 08/25/20
14.9500 -6.35%
on 08/17/20
-1.3500 (-8.79%)
since 07/06/20
3-Month
14.0000 unch
on 08/25/20
16.5000 -15.15%
on 05/26/20
-2.4000 (-14.63%)
since 05/20/20
52-Week
14.0000 unch
on 08/25/20
17.9500 -22.01%
on 12/24/19
-2.1400 (-13.26%)
since 07/24/19

Most Recent Stories

More News
Grifols to acquire Alkahest to enhance discovery research and development to identify innovative therapies for age-related diseases based upon an understanding of the human plasma proteome

BARCELONA, Spain , and SAN CARLOS, Calif. , Sept. 7, 2020 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in...

GRFS : 16.57 (-0.84%)
GIKLY : 14.0000 (-2.78%)
ICU Medical Broadens its Non-PVC/Non-DEHP IV Solutions Portfolio by Entering Long-Term U.S. Distribution Agreement with Grifols for Certain Core IV Solution Products

SAN CLEMENTE, Calif., Aug. 10, 2020 /PRNewswire/ --  ICU Medical Inc. (NASDAQ: ICUI) today announced that it has entered into a long-term agreement with Grifols to distribute a full line...

ICUI : 186.47 (+1.65%)
GRFS : 16.57 (-0.84%)
GIKLY : 14.0000 (-2.78%)
Grifols starts production of its hyperimmune immunoglobulin as a potential passive immune therapy against COVID-19

BARCELONA, Spain , June 11, 2020 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of therapies with plasma-derived proteins with a track record of...

GRFS : 16.57 (-0.84%)
GIKLY : 14.0000 (-2.78%)
Racing Against Time, Medical Researchers, Life Science Companies and COVID-19 Survivors Launch National Campaign to Drive Blood Plasma Donation

REDMOND, Wash. and NEW YORK , May 26, 2020 /PRNewswire/ -- A coalition of world-leading medical and research institutions, blood centers, life science companies, technology companies,...

MSFT : 207.82 (+2.28%)
CSLLY : 105.2100 (+0.21%)
GRFS : 16.57 (-0.84%)
TAK : 18.53 (unch)
GIKLY : 14.0000 (-2.78%)
Grifols Procleix Panther System with Automation Ready Technology (ART) receives FDA Approval

BARCELONA, Spain , May 7, 2020 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative...

GRFS : 16.57 (-0.84%)
GIKLY : 14.0000 (-2.78%)
Grifols launches new 3-mL (900-IU) vial for high-potency HyperRAB® (rabies immune globulin [human])

BARCELONA, Spain , April 28, 2020 /PRNewswire/ -- Grifols (MCE:GRF, MCE:GRF.P NASDAQ:GRFS), a leading global producer of plasma-derived medicines, today announced the launch of a new 3-mL (900-IU)...

GRFS : 16.57 (-0.84%)
GIKLY : 14.0000 (-2.78%)
People Who Have Recovered from COVID-19 Can Now Donate their Convalescent Plasma in select Grifols U.S. Plasma Donor Centers

BARCELONA, Spain , April 20, 2020 /PRNewswire/ -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company with a track record of more than 100 years and a recognized leader in the...

GRFS : 16.57 (-0.84%)
GIKLY : 14.0000 (-2.78%)
Grifols 2019 Annual Report on Form 20-F Filed With the SEC on April 6, 2020

BARCELONA, Spain , April 6, 2020 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS) announced that it has filed its 2019 Annual Report on Form 20-F with the United States...

GRF : 6.82 (+0.89%)
GRFS : 16.57 (-0.84%)
GIFLF : 27.2524 (-4.04%)
GIFOF : 16.7920 (+2.15%)
GIKLY : 14.0000 (-2.78%)
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19

BARCELONA, Spain , March 25, 2020 /PRNewswire/ -- Grifols today announces that it has entered into a formal collaboration with the United States Biomedical Advanced Research Development Authority...

GRFS : 16.57 (-0.84%)
GIKLY : 14.0000 (-2.78%)
Grifols PharmacyKeeper ranked No. 1 in KLAS rating, extends category leadership

BARCELONA, Spain , Feb. 13, 2020 /PRNewswire/ --   Grifols (MCE:GRF, MCE:GRF.P NASDAQ:GRFS), a leading global producer of plasma-derived medicines and provider of technologies and services...

GRFS : 16.57 (-0.84%)
GIKLY : 14.0000 (-2.78%)
Trade GIKLY with:

Key Turning Points

2nd Resistance Point 14.0000
1st Resistance Point 14.0000
Last Price 14.0000
1st Support Level 14.0000
2nd Support Level 14.0000

See More

52-Week High 17.9500
Fibonacci 61.8% 16.4411
Fibonacci 50% 15.9750
Fibonacci 38.2% 15.5089
Last Price 14.0000
52-Week Low 14.0000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar